1. Home
  2. ADIL vs NBY Comparison

ADIL vs NBY Comparison

Compare ADIL & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • NBY
  • Stock Information
  • Founded
  • ADIL 2010
  • NBY 2000
  • Country
  • ADIL United States
  • NBY United States
  • Employees
  • ADIL N/A
  • NBY N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • ADIL Health Care
  • NBY
  • Exchange
  • ADIL Nasdaq
  • NBY Nasdaq
  • Market Cap
  • ADIL 7.7M
  • NBY 6.3M
  • IPO Year
  • ADIL 2018
  • NBY 2007
  • Fundamental
  • Price
  • ADIL $0.36
  • NBY $1.24
  • Analyst Decision
  • ADIL Strong Buy
  • NBY Strong Buy
  • Analyst Count
  • ADIL 2
  • NBY 1
  • Target Price
  • ADIL $4.75
  • NBY $0.85
  • AVG Volume (30 Days)
  • ADIL 745.1K
  • NBY 521.0K
  • Earning Date
  • ADIL 11-12-2025
  • NBY 11-10-2025
  • Dividend Yield
  • ADIL N/A
  • NBY N/A
  • EPS Growth
  • ADIL N/A
  • NBY N/A
  • EPS
  • ADIL N/A
  • NBY 0.41
  • Revenue
  • ADIL N/A
  • NBY $9,781,000.00
  • Revenue This Year
  • ADIL N/A
  • NBY $23.91
  • Revenue Next Year
  • ADIL N/A
  • NBY $32.05
  • P/E Ratio
  • ADIL N/A
  • NBY $3.21
  • Revenue Growth
  • ADIL N/A
  • NBY 113.47
  • 52 Week Low
  • ADIL $0.22
  • NBY $0.46
  • 52 Week High
  • ADIL $1.30
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 47.93
  • NBY 46.82
  • Support Level
  • ADIL $0.35
  • NBY $1.08
  • Resistance Level
  • ADIL $0.39
  • NBY $1.28
  • Average True Range (ATR)
  • ADIL 0.03
  • NBY 0.15
  • MACD
  • ADIL -0.00
  • NBY 0.01
  • Stochastic Oscillator
  • ADIL 27.67
  • NBY 59.07

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: